Nutex Health, INC Form 4 insider transactions
NASDAQ
Nutex Health's Chief Operating Officer, Joshua DeTillio, recently purchased additional shares of the company's common stock.
NASDAQ
Nutex Health's CEO, Thomas Vo, acquired 22,709 shares of common stock on July 12, 2024, as part of the Merger Agreement related to an Under Construction Hospital.
NASDAQ
Elisa Luqman, Chief Legal Officer of Nutex Health, Inc., was granted 37,500 restricted stock units (RSUs) on June 28, 2024, according to a Form 4 filing with the SEC.
NASDAQ
Pamela Montgomery, Chief Legal Officer-Healthcare at Nutex Health, Inc., reports the acquisition of 37,500 Restricted Stock Units (RSUs) on June 28, 2024.
NASDAQ
Form 4: Nutex Health's Chief Medical Officer, Michael L. Chang, Acquires 37,500 Restricted Stock Units
Michael L. Chang, Chief Medical Officer of Nutex Health, Inc., reports the acquisition of 37,500 Restricted Stock Units (RSUs) on June 28, 2024, which will vest in three equal installments.
NASDAQ
Nutex Health's Chief Operating Officer, Joshua DeTillio, reports the acquisition of 63,750 Restricted Stock Units (RSUs) on June 28, 2024, which will vest in three equal installments.
NASDAQ
Nutex Health's CFO, Jon Christian Bates, was granted 45,000 Restricted Stock Units (RSUs) on June 28, 2024, which will vest in three equal annual installments starting March 1, 2025.
NASDAQ
Warren Hosseinion, President of Nutex Health, Inc., reports the acquisition of 113,265 Restricted Stock Units (RSUs) on June 28, 2024, according to a Form 4/A filing with the SEC.
NASDAQ
Warren Hosseinion, President of Nutex Health, Inc., reports the acquisition of 113,265 Restricted Stock Units (RSUs) on June 28, 2024, which will vest in three equal installments.
NASDAQ
Nutex Health's CEO, Thomas Vo, was granted 150,000 Restricted Stock Units (RSUs) that will vest in three equal installments.
NASDAQ
Nutex Health's Chief Operating Officer, Joshua DeTillio, recently purchased 20,000 shares of the company's common stock at an average price of $0.54 per share.
NASDAQ
Nutex Health's CEO, Thomas Vo, has been actively purchasing company stock, increasing his indirect holdings through Micro Hospital Holding LLC and Vo Family Limited Partnership.
NASDAQ
Nutex Health's CFO, Jon Christian Bates, settled restricted stock units (RSUs) for shares of common stock on March 12, 2024.
NASDAQ
Pamela Montgomery, Chief Legal Officer of Nutex Health, Inc., settled restricted stock units (RSUs) for common stock on March 12, 2024.